Rare lephants
Screener

Emmaus Life Sciences, Inc.

EMMA ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
3 Oct 6, 2022 FORM 3 SUBMISSION
3 Oct 6, 2022 FORM 3 SUBMISSION
8-K Oct 6, 2022 CURRENT REPORT
8-K Sep 30, 2022 CURRENT REPORT
8-K Aug 19, 2022 CURRENT REPORT
8-K Aug 15, 2022 CURRENT REPORT
10-Q Aug 15, 2022 10-Q
8-K Aug 10, 2022 CURRENT REPORT
4 Jul 25, 2022 FORM 4 SUBMISSION
10-K/A Jul 1, 2022 AMENDMENT NO. 1 TO FORM 10-K
D Jun 30, 2022
8-K Jun 10, 2022 CURRENT REPORT
4 Jun 3, 2022 FORM 4 SUBMISSION
4 Jun 2, 2022 FORM 4 SUBMISSION
4 May 19, 2022 FORM 4 SUBMISSION
8-K May 13, 2022
10-Q May 13, 2022 10-Q
4 Apr 12, 2022 FORM 4 SUBMISSION
8-K Mar 31, 2022 CURRENT REPORT
10-K Mar 31, 2022 10-K
4 Mar 2, 2022 FORM 4 SUBMISSION
4 Feb 28, 2022 FORM 4 SUBMISSION
4 Feb 28, 2022 FORM 4 SUBMISSION
4 Feb 23, 2022 FORM 4 SUBMISSION
4 Feb 18, 2022 FORM 4 SUBMISSION
← Newer Page 5 of 50 · 1238 filings Older →